Kailera Therapeutics, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Kailera Therapeutics, Inc. is publicly traded on NASDAQ under the ticker KLRA.
Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1...
Can you invest in Kailera Therapeutics, Inc.?
Yes. Kailera Therapeutics, Inc. trades publicly on NASDAQ as KLRA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kailera Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.